ArticleJournal of thoracic disease2021

Serum β-klotho is a potential biomarker in the prediction of clinical outcomes among patients with NSCLC.

Juan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.